Abstract:Editorial Office Annals of Translational Medicine Submitted Jul 21, 2024. Accepted for publication Aug 02, 2024. Published online Sep 05, 2024. doi: 10.21037/atm-2024-9 Erratum to: Ann Transl Med 2021;9:533 The article (1) titled "ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway" (doi: 10.21037/atm-20-7005), unfortunately contains several errors that need to be corrected. The image in the upper right corner of Figure 2F, which represents the migration of the control shRNA-expressing MDA-MB-231 cells, was selected incorrectly. This image should be replaced with the correct one. In the legend of Figure 2, the order of the parts corresponding to Figure 2E-2I was incorrect. The correct order is: (E) colony formation assay on MDA-MB-231; (F) migration assay on MDA-MB-231; (G) migration assay on MDA-MB-468; (H) invasion assay on MDA-MB-231; (I) invasion assay on MDA-MB-468. The caption "MDA-MB-468" in Figure 4 was accidentally misplaced between Figure 4D and Figure 4F, which should be at the bottom of Figure 4C . In the legend of Figure 4, the order of the parts corresponding to Figure 4C-4F was incorrect. The correct order is: (C) CCK-8 assay on MDA-MB-468; (D) migration assay on MDA-MB-231; (E) migration assay on MDA-MB-468; (F) invasion assay on MDA-MB-231. Figure 2F in the original article: The legend of Figure 2 in the original article: Caption "MDA-MB-468" in Figure 4 in the original article: The legend of Figure 4 in the original article: The updated version of Figure 2 , containing the correct image for the "Control" in Figure 2F , and the updated version of Figure 4 with the correct position of the caption "MDA-MB-468", together with the correct legends for both figures, are shown below. These errors did not significantly affect either the results or the conclusions of the paper. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Erratum: Therapeutic Potential of HIV Nosode 30c as Evaluated in A549 Lung Cancer Cells

Circ0021205 Aggravates the Progression of Non-Small Cell Lung Cancer by Targeting Mirna-16-5p/vegfa

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Corrigendum to “knockdown of Herp Alleviates Hyperhomocysteinemia Mediated Atherosclerosis Through the Inhibition of Vascular Smooth Muscle Cell Phenotype Switching” [int. J. Cardiol. 269 (2018) 242–249]

Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Correction To: Clinical Diversity of Invasive Cryptococcosis in AIDS Patients from Central China: Report of Two Cases with Review of Literature

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Retraction Retracted : Decursin Isolated from Angelica gigas Nakai Rescues PC 12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf 2-Mediated Upregulation of Heme Oxygenase-1 : Potential Roles of MAPK Evidence-Based Complementary and Alternative Medicine

Correction To: Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cells: the Effect of Combining RNA Interference with Tyrosine Kinase Inhibitors or Cetuximab

Erratum: "Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges". Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells and Manuela Funke-Chambour. ERJ Open Res 2022; 8: 00115-2022

[Corrigendum] Role of cysteine‐rich angiogenic inducer 61 in fibroblast‐like synovial cell proliferation and invasion in rheumatoid arthritis

Erratum: Candida krusei pneumonia in graft-versus-host disease after allogeneic hematopoietic stem cell transplant for paroxysmal nocturnal hemoglobinuria: a case report: erratum

[Corrigendum] All‑ trans retinoic acid alters the expression of the tight junction proteins Claudin‑1 and ‑4 and epidermal barrier function‑associated genes in the epidermis

Correction: Immunomodulatory activity and inhibitory effects of Viscum album on cancer cells, its safety profiles and recent nanotechnology development

Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

Correction: Corrigendum: Patient-specific Hepatocyte-Like Cells Derived from Induced Pluripotent Stem Cells Model Pazopanib-Mediated Hepatotoxicity

Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal

[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‐4 in vitro and in vivo

Erratum: Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

Erratum to ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway